-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Immix Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
- Immix Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $186K, a 18.7% decline year-over-year.
- Immix Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $1.02M, a 77.9% increase year-over-year.
- Immix Biopharma, Inc. annual Nonoperating Income (Expense) for 2024 was $1.02M, a 77.9% increase from 2023.
- Immix Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was $572K.
- Immix Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$497.000, a 100% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)